RNA-seq is the gold standard for next-generation-sequencing-based quantification of gene expression, but it requires high sample input amounts, has bias caused by RNA extraction, and requires time-costly data analysis pipelines. The HTG EdgeSeq platform can be used as an alternative to RNA-seq.
This whitepaper compares the performance of the HTG EdgeSeq Oncology Biomarker and Precision Immuno-Oncology gene expression profiling panels to RNA-seq, using approximately 1,200 formalin-fixed, paraffin-embedded tumor tissue samples. HTG EdgeSeq panels require less sample input and offer a faster workflow. Data generated by the EdgeSeq platform is processed using a fully integrated web-based data analysis pipeline.
Offered Free by: HTG Molecular Diagnostics
See All Resources from: HTG Molecular Diagnostics